OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
MDIN
MedGen, Inc.
Common Stock
MedGen, Inc.
100 Queen St E, Suite 203
Toronto, ON M5C 1S6
Canada
Business Description
MedGen, Inc. is a MedTech and Lifesciences Company Focused on Technology Commercialization and Investment. The Company operates in Four Segments, including Biomedical, Healthcare, Precision Medicine and Pharmaceutical. MedGen Portfolio Companies, Divisions and Subsidiaries offers a range of Products, Solutions and Services for Sale and Licensing. The First Subsidiary emb3Ded Advanced Technologies, is Additive Manufacturing @ the Micro & Nanoscale with Initial Focus on Biotechnology Utilizing 3D Bioprinting. Producing Consumable Materials and Products that Mimic the Natural Shape of Tissues in the Human Body. The Second Subsidiary, will leverage its Current Patents to Produce Artificial Human ...
More
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Unaudited
Latest Report
CIK
0001045707
Fiscal Year End
9/30
Company Officers & Contacts
Johnny Rodrigues
CEO
Board of Directors
Johnny Rodrigues
CEO
Other Company Insiders
Not available
Service Providers
Securities Counsel
The Doney Law Firm4955 Durango Drive,
Las Vegas, NV 89113
Profile Data
SIC - Industry Classification
Not Available
Incorporation Information
WY, US, 1996
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Formerly=Northstar Global Business Services, Inc. until 7-2015
Formerly=Med Gen, Inc. until 8-2010
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
